FDA Advisers Consider Regulations and Ethics of 'Artificial Womb' for Premature Babies
-
FDA advisers met to discuss future of 'artificial womb' for human infants, considering regulations and ethics.
-
Artificial womb could help extremely premature babies survive without long-term health issues.
-
Researchers have tested devices on animals, seeing positive development, but not yet tested on humans.
-
Experts say animal trials first needed to determine safety before human trials.
-
Advisers discussed extensive follow-up needed to check for long-term health effects in children if tested on humans.